Claude Poisson

Title: Claude Poisson: Innovator in Neuropharmacology

Introduction

Claude Poisson is a notable inventor based in Riom, France. He has made significant contributions to the field of neuropharmacology, particularly through his innovative patent work. With a total of 3 patents, Poisson has focused on developing compounds that exhibit therapeutic potential.

Latest Patents

Among his latest patents, one notable invention is the neuroleptic/antidepressant compound, which features 4-[4- or 6-(trifluoromethyl-2-pyridinyl)]-1-piperazinylalkyl substituted lactam derivatives. This invention relates to compounds that have a general structure designed to enhance neuroleptic and antidepressant effects. Another significant patent involves pyridinylpiperazine derivatives, which display improved preferential serotonin-1A binding activity. These compounds are characterized by a specific formula that allows for various substitutions, enhancing their therapeutic efficacy.

Career Highlights

Claude Poisson is associated with Akzo N.V., a company known for its focus on innovation in the chemical sector. His work has contributed to advancements in the development of neuropharmacological agents, showcasing his expertise in the field.

Collaborations

Throughout his career, Poisson has collaborated with notable colleagues, including Patrick Carlier and Andre J Monteil. These collaborations have likely enriched his research and development efforts, leading to the successful creation of his patented compounds.

Conclusion

Claude Poisson stands out as an influential inventor in the realm of neuropharmacology. His innovative patents and collaborations reflect his commitment to advancing therapeutic solutions. His work continues to impact the field positively.